SEC Form D private-offering filing
NurExone Biologic Inc.
A new SEC Form D private-offering notice from Technion City, Haifa, a $279,910 filer-stated offering target in Biotech. The source filing is one click away.
Publicly traded biotechnology company, listed as TSXV NRX and OTCQB NRXBF, developing exosome based regenerative therapies for spinal cord injury and other central nervous system conditions.
Filed 2026-03-18Filed to raise $279,910First money in 2026-03-10Raised so far $279,910HQ (as filed) Technion City, HaifaSector Biotech ✓Stage (inferred) Pre-seedCall status Non-US principal office
Source linked the Form D on EDGAR↗Website verified nurexone.com↗Named in the filing 6 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.